Clinical Trials Browser

Mesothelioma, Malignant × Immunotherapy, Adoptive × 1 year × Clear all

NCT04577326 2025-07-25

Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma

Phase 1 Active not recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant